(Q37582425)

21 August 2017

1 reference

title

Viral vectors in malaria vaccine development (English)

1 reference

21 August 2017

0 references

1 reference

1 reference

2

1 reference

21 August 2017

K J Limbach

1

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

31

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

501-519

1 reference

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

The complexity of protective immunity against liver-stage malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2009.01141.X

10.1111/J.1365-3024.2009.01141.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference